Loading...
Molecular subtyping of leiomyosarcoma with 3′ end RNA sequencing
Leiomyosarcoma (LMS) is a malignant neoplasm with smooth muscle differentiation. Little is known about its molecular heterogeneity and no targeted therapy currently exists for LMS. We performed expression profiling on 99 cases of LMS with 3′ end RNA sequencing (3SEQ) and demonstrated the existence o...
Saved in:
Published in: | Genom Data |
---|---|
Main Authors: | , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Elsevier
2015
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4521214/ https://ncbi.nlm.nih.gov/pubmed/26240788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gdata.2015.06.029 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|